Morepen Laboratories

Morepen Laboratories

46.81
-0.14
(-0.30%)
Market Cap
2,564.97 Cr
EPS
2.20
PE Ratio
27.77
Dividend Yield
0.43 %
Industry
Healthcare
52 Week High
100.90
52 Week Low
42.00
PB Ratio
2.22
Debt to Equity
0.07
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,594.60
#1 3,82,597.95
33.18
#1 54,729.00
9.71
#1 10,980
-19.84
36.22
6,142.50
1,63,064.08
70.56
9,712.00
18.67
2,191
26.74
42.64
1,591.20
1,28,522.47
23.65
28,409.50
7.12
5,291
9.88
60.58
3,559.90
1,20,483.19
59.97
11,539.40
6.99
1,911
19.91
48.61
1,264.60
1,05,539.86
#1 18.52
33,741.20
16.73
5,725
1.26
51.05
2,473.30
1,02,080.20
54.03
12,744.20
#1 20.90
2,007
-18.14
44.32
981.95
98,807.15
21.09
23,511.00
18.55
4,615
2.60
50.45
1,897.70
86,667.10
23.49
22,909.50
13.74
3,306
#1 51.64
43.44
31,535.00
67,009.67
46.08
6,684.70
9.64
1,414
11.55
37.94
5,308.50
63,471.08
28.27
13,458.30
3.70
2,216
21.39
65.44
Forecast
Actual
Growth Rate
Revenue Growth
7.36 %
Net Income Growth
22.15 %
Cash Flow Change
-56.30 %
ROE
-12.81 %
ROCE
-18.00 %
EBITDA Margin (Avg.)
3.85 %

Quarterly Financial Results

Quarterly Financials
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
132
151
156
172
164
174
215
220
203
216
235
208
259
340
310
291
388
398
399
372
303
404
350
367
404
425
449
427
459
443
458
471
430
Expenses
121
130
137
154
152
157
195
197
184
198
215
188
231
305
278
256
343
353
364
350
288
374
328
348
375
388
394
375
404
394
417
424
401
EBITDA
11
20
19
18
12
17
19
23
20
18
20
21
28
36
33
35
45
45
35
22
16
30
22
19
29
37
55
53
55
49
42
47
29
Operating Profit %
7 %
13 %
12 %
10 %
7 %
10 %
8 %
10 %
10 %
7 %
7 %
9 %
10 %
9 %
10 %
11 %
11 %
11 %
8 %
5 %
5 %
7 %
6 %
4 %
7 %
8 %
11 %
11 %
11 %
10 %
8 %
9 %
6 %
Depreciation
9
8
8
10
9
10
10
11
12
8
9
9
8
8
8
7
7
7
7
7
7
7
7
7
8
8
8
10
6
2
5
17
9
Interest
1
1
1
1
0
0
0
1
0
0
1
1
0
0
1
-0
0
-9
1
1
0
1
1
1
0
1
2
1
1
1
1
5
4
Profit Before Tax
1
11
10
7
3
7
9
11
8
9
11
11
20
28
24
28
39
47
27
14
8
22
14
11
21
29
44
42
48
46
35
26
16
Tax
0
0
0
0
0
-0
0
0
0
5
0
0
0
0
0
1
8
10
6
2
3
7
5
3
6
7
12
14
12
11
9
5
4
Net Profit
1
11
10
7
3
7
9
11
8
4
11
11
19
27
24
27
31
37
22
12
6
16
9
8
15
21
32
29
36
35
27
20
11
EPS in ₹
0.03
0.25
0.23
0.15
0.05
0.16
0.20
0.23
0.17
0.09
0.24
0.25
0.43
0.60
0.53
0.59
0.68
0.83
0.48
0.27
0.12
0.33
0.15
0.16
0.29
0.42
0.63
0.54
0.71
0.65
0.49
0.35
0.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
489
524
538
586
615
664
858
1,070
1,111
1,293
1,778
Fixed Assets
323
297
272
264
236
216
225
252
267
307
489
Current Assets
115
157
192
243
300
372
527
734
756
889
1,159
Capital Work in Progress
0
0
0
0
0
0
2
14
17
25
28
Investments
0
0
0
0
0
1
1
0
0
1
85
Other Assets
167
227
267
321
379
446
631
804
827
960
1,176
Total Liabilities
489
524
538
586
615
664
858
1,070
1,111
1,293
1,778
Current Liabilities
128
167
325
340
339
351
404
457
321
402
501
Non Current Liabilities
74
58
18
20
23
28
30
36
37
44
91
Total Equity
287
300
196
226
253
284
424
578
752
847
1,187
Reserve & Surplus
78
91
106
136
163
194
291
457
651
745
1,047
Share Capital
210
210
90
90
90
90
90
96
102
102
110

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-5
3
-1
4
4
28
-26
6
-5
10
Investing Activities
-32
-27
-14
-27
-13
-13
-70
-32
-47
-83
-322
Operating Activities
51
50
41
63
17
11
51
-60
-91
73
32
Financing Activities
-19
-27
-24
-38
-0
6
47
66
144
5
300

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
May 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
34.54 %
34.54 %
34.54 %
34.54 %
38.38 %
36.74 %
36.74 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
35.65 %
35.65 %
35.65 %
35.65 %
35.65 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.29 %
0.00 %
1.85 %
1.67 %
7.72 %
2.08 %
2.22 %
1.94 %
1.72 %
DIIs
2.89 %
2.03 %
1.26 %
1.16 %
1.07 %
4.07 %
4.07 %
3.60 %
3.74 %
2.93 %
2.33 %
2.28 %
2.00 %
2.15 %
2.15 %
2.90 %
1.70 %
1.64 %
1.67 %
1.51 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Public / Retail
42.97 %
43.89 %
44.82 %
45.18 %
42.50 %
40.88 %
40.91 %
43.63 %
44.03 %
45.04 %
45.49 %
45.56 %
44.44 %
45.03 %
45.22 %
41.89 %
48.16 %
48.35 %
48.76 %
49.35 %
Others
19.60 %
19.54 %
19.38 %
19.12 %
18.05 %
18.31 %
18.29 %
14.53 %
13.99 %
13.80 %
13.95 %
12.64 %
15.33 %
12.74 %
12.74 %
11.83 %
12.41 %
12.12 %
11.96 %
11.76 %
No of Share Holders
1,65,609
2,30,611
2,44,924
2,55,155
2,60,933
2,83,547
2,87,115
2,87,370
3,06,030
3,06,150
3,01,832
3,04,001
3,04,289
3,36,019
3,48,766
3,52,839
4,30,929
4,48,361
4,68,860
4,61,180

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.2
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.43

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
06 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
06 Sept 2025 56.56 46.95
30 Aug 2025 DIVIDEND Dividend
₹ 0.20 /share
29 Aug 2025 56.23 46.95
02 Feb 2023 CHANGE OF NAME Change Of Name
NA
02 Feb 2023 28.05 28.05
18 Mar 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
18 Mar 2024 53.30 41.96
28 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Sept 2024 96.19 86.63
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 82.35 83.34
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 64.67 66.62
10 Feb 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
10 Feb 2025 68.14 61.26
12 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 May 2025 59.26 56.23
06 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Aug 2025 58.45 56.56

Announcements

Announcement under Regulation 30 (LODR)-Credit Rating6 days ago
Intimation Of Incorporation Of A Step Down Subsidiary CompanyAug 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Letter To Members (No E-Mail Id Registered) Comprising Weblink Of The Annual Report : 2024-25Aug 12, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 12, 2025
Notice Of 40Th AGMAug 12, 2025
Reg. 34 (1) Annual Report.Aug 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 06, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 06, 2025
Approval Of Notice Of AGM Scheduled To Be Held On Saturday September 06 2025Aug 06, 2025
Intimation For Fixation Of Record Date For Payment Of Final Dividend I.E. August 30 2025Aug 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 06, 2025
Q1-FY 26 Unaudited Financial ResultsAug 06, 2025
Board Meeting Outcome for For Q1 FY26 Results And OthersAug 06, 2025
Board Meeting Intimation for Q-1 FY26 ResultsAug 01, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Jul 31, 2025
Intimation Of Formation Of A Step Down Subsidiary CompanyJul 25, 2025
Incorporation Of A Step-Down Subsidiary Company In Mainland Dubai United Arab Emirates.Jul 22, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Jun 30, 2025
Closure of Trading WindowJun 27, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 21, 2025
Incorporation Of A Wholly Owned Subsidiary In Dubai United Arab Emirates.Jun 18, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 04, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsMay 23, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)May 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 13, 2025
Results - Q4 & FY 25May 12, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 12, 2025
Appointment Of Cost Auditors And Internal Auditors Of The CompanyMay 12, 2025
Intimation Of Formation Of A Step Down Subsidiary Company In Dubai UAEMay 12, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsMay 12, 2025
Corporate Action-Board approves DividendMay 12, 2025
Audited Financial Results (Consolidated And Standalone) For The Quarter / Year Ended March 31 2025May 12, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of DirectorsMay 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 08, 2025
Board Meeting Intimation for Financial Results Q4 & FY25 And Recommend Final Dividend If Any.May 05, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 05, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 01, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 29, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 28, 2025
Intimation Of Formation Of A Wholly Owned Subsidiary In Dubai United Arab EmiratesApr 28, 2025
Launch Of Four New ProductsApr 24, 2025
Intimation Of Name Change Of Subsidiary CompanyApr 17, 2025

Technical Indicators

RSI(14)
Neutral
28.13
ATR(14)
Less Volatile
2.07
STOCH(9,6)
Neutral
45.75
STOCH RSI(14)
Neutral
71.89
MACD(12,26)
Bullish
0.16
ADX(14)
Strong Trend
34.81
UO(9)
Bearish
38.10
ROC(12)
Downtrend And Accelerating
-0.40
WillR(14)
Neutral
-76.24

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.15%
-196
-0.01%
-0.03%